Personalized treatment using tumor test results for aggressive cancers
Part of Cancer clinical trials.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older with an aggressive solid tumor cancer (including rare cancers).
- Your cancer situation fits at least one category: advanced/unresectable/metastatic, or no expected standard treatment benefit.
- You either have not had cancer treatment yet for this diagnosis, or you’ve had at least one type of whole-body (systemic) therapy before.
- Your cancer must have measurable tumors on scans or exam (a size threshold is required).
- You must be able to swallow pills and have lab results showing your blood, liver, and kidneys can handle treatment.
- You must be willing to avoid pregnancy and breastfeeding and use reliable birth control if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial matches people with advanced cancer to a targeted treatment based on a genetic (DNA) or protein (IHC) test from their tumor. It’s for cancers that are no longer responding to standard treatment or where no standard option is available.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.
This trial looks at your tumor (and blood) to find helpful targets so doctors can match you to an experimental targeted therapy, if one fits. It may help by using detailed “tumor profiling” to choose treatments more precisely for your cancer.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
This trial studies how doctors choose individualized cancer treatment for people with pancreatic cancer. It may help them learn which treatment choices work best for different patients.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.